Daily Podcasts Video Research

One step closer to a cure for Alzheimer's? A Canadian expert weighs in

star 0 Science Culture

JL;DR SUMMARY In this episode, Dr. Sharon Cohen discusses the significance of aducanumab, a newly FDA-approved drug for Alzheimer's, which while promising, raises concerns regarding side effects and efficacy. A way out west there was a fella, fella I want to tell you about, fella by the name of Jeff Lebowski.

  • At least, that was the handle his lovin' parents gave him, but he never had much use for it himself.
  • This Lebowski, he called himself the Dude.
  • Now, Dude, that's a name no one would self-apply where I come from.
  • But then, there was a lot about the Dude that didn't make a whole lot of sense to me.
  • And a lot about where he lived, likewise. But then again, maybe that's why I found the place s'durned innarestin'.
JL;DR members get full summaries and key points of all podcast episodes in the archive, including this one. Donate & listen smarter »

Tags

Lifestyle Changes  Alzheimer's  Fda Approval  Neurology  Brain Health  Aducanumab  Dr. Sharon Cohen  Toronto Memory Program  Amyloid  Early Diagnosis 

Places mentioned

No places identified yet.
This podcast episode was indexed and curated by Cairo, JL;DR's web crawler.
Cairo Item ID 23773
Cairo Source ID 72
Retrieved 2024-05-23 16:41:17 UTC
Curated 2024-08-29 19:20:20 UTC